Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease
Cardiovascular disease increases risks of chronic kidney disease (CKD) progression and mortality in type 2 diabetes.
Authors
- L. Sreenivasamurthy
- Gil Chernin (ORCID: https://orcid.org/0000-0001-7514-156X)
- Soo Kun Lim (ORCID: https://orcid.org/0000-0001-7589-5150)
- Willem A. Bax (ORCID: https://orcid.org/0000-0002-2177-1475)
- Florian M.M. Baeres
- Nicolas Belmar
- Derrick Musinga
- J F E Mann
- V Perkovic
- M Shamkhalova
- K W Mahaffey
- R E Pratley
- K R Tuttle
- P Rossing
- George L. Bakris
- Paul M Ridker (ORCID: https://orcid.org/0000-0003-1249-4522)
- Casper N. Bang
- David Z.I. Cherney
- Roland Schmieder
Institutions
- University of Copenhagen (DK)
- Brigham and Women's Hospital (US)
- Steno Diabetes Centers (DK)
- University of Toronto (CA)
- Novo Nordisk (Denmark) (DK)
- Providence College (US)
- University of Washington (US)
- Kaplan Medical Center (IL)
- Inland Northwest Health Services (US)
- CARE Hospitals (IN)
- UNSW Sydney (AU)
- University of Malaya (MY)
- Endocrinology Research Center (RU)
- Universitätsklinikum Erlangen (DE)
- Katholische Stiftungshochschule München (DE)
- Translational Research Institute for Metabolism and Diabetes (US)
- Stanford Medicine (US)
- Center for Clinical Research (United States) (US)
- Excelitas Technologies (Germany) (DE)
Publication Details
- Journal
- Journal of the American College of Cardiology
- Published
- 2026-06-01
- DOI
- https://doi.org/10.1016/j.jacc.2026.02.5125
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 12.38